Mature T-Cell and NK-Cell Neoplasm — Trials

Mature T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

825 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 312 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00221039	Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A	completed	Phase 4	7	M.D. Anderson Cancer CenterOTHER	1	Aug 17, 2018	clinicaltrials
NCT01482962	Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma	completed	Phase 3	271	Millennium Pharmaceuticals, Inc.INDUSTRY	31	Jul 31, 2018